Survey on Cardiovascular Events in Patients With Metabolic Disease on Chronic Carnitine Supplementation

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02311270

Enrollment

106

Registered

2014-12-08

Start date

2014-09-30

Completion date

2016-06-30

Last updated

2016-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Disorders

Brief summary

The purpose of this study is to learn about the effects of long term carnitine use in patients with metabolic disorders and its potential relationship to cardiovascular events.

Detailed description

This online cross-sectional survey will examine the self-reported long-term carnitine use in patients with metabolic disorders and any potential relationship to cardiovascular events.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Healthy volunteers

Yes

Inclusion criteria

* Diagnosis of mitochondrial disease or any other metabolic disorder * Any age group * NAMDC or RDCRN registry participant

Exclusion criteria

* Inability to provide informed consent and complete survey * Lack of participation in NAMDC or RDCRN registry

Design outcomes

Primary

Measure	Time frame
Assess how many patients with metabolic disorders are on chronic carnitine supplementation.	Up to one year from study activation.

Secondary

Measure	Time frame
Assess how many patients who are on chronic carnitine supplementation have experienced a cardiovascular event.	Up to one year from study activation

Countries

United States

Outcome results